Sven Becker Selected Research

Nose Diseases (Disease, Nose)

8/2014	Drug delivery to paranasal sinuses using pulsating aerosols.
9/2013	Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sven Becker Research Topics

Disease

44	Neoplasms (Cancer) 05/2022 - 08/2002
18	Breast Neoplasms (Breast Cancer) 06/2020 - 01/2005
9	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 10/2011
7	Squamous Cell Carcinoma of Head and Neck 06/2022 - 01/2015
7	Head and Neck Neoplasms (Head and Neck Cancer) 11/2021 - 01/2015
7	Hypersensitivity (Allergy) 06/2021 - 01/2011
6	COVID-19 08/2021 - 01/2020
6	Rhinosinusitis 01/2021 - 01/2013
5	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2014
5	Inflammation (Inflammations) 01/2022 - 01/2012
4	Asthma (Bronchial Asthma) 01/2021 - 01/2015
4	Allergic Rhinitis 01/2019 - 01/2012
3	Infections 03/2022 - 04/2019
3	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 01/2019
2	Vulvar Neoplasms (Vulvar Cancer) 01/2022 - 11/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2019
2	Chromosomal Instability (Chromosome Stability) 07/2021 - 01/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2017
2	Hemorrhage 01/2019 - 10/2017
2	Leiomyoma (Uterine Fibroids) 01/2018 - 10/2017
2	Carcinogenesis 11/2017 - 10/2014
2	Eosinophilia 06/2016 - 01/2012
2	Nose Diseases (Disease, Nose) 08/2014 - 09/2013
2	Residual Neoplasm 10/2013 - 01/2008
2	Circulating Neoplastic Cells 02/2012 - 02/2012
1	Foreign-Body Reaction 03/2022
1	Ischemia 03/2022
1	Burns 02/2022
1	Wounds and Injuries (Trauma) 02/2022
1	Genomic Instability 07/2021
1	Chronic Urticaria 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2013
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
6	Phosphotransferases (Kinase)IBA 07/2021 - 01/2015
6	AllergensIBA 06/2021 - 05/2010
5	Biological ProductsIBA 12/2021 - 12/2007
5	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 02/2014
5	Caspase 8 (Caspase-8)IBA 01/2021 - 03/2014
5	Phenobarbital (Luminal)FDA Link 08/2015 - 10/2013
4	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 03/2020
4	CytokinesIBA 01/2022 - 01/2012
4	Estrogen ReceptorsIBA 06/2020 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
3	Indicators and Reagents (Reagents)IBA 09/2021 - 02/2012
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2015
3	Keratins (Keratin)IBA 05/2006 - 01/2005
2	Polo-Like Kinase 1IBA 01/2022 - 05/2018
2	Polo-like KinasesIBA 12/2021 - 01/2021
2	Ion Channels (Ion Channel)IBA 11/2021 - 09/2021
2	Budesonide (Pulmicort)FDA LinkGeneric 08/2021 - 01/2021
2	Taxoids (Taxanes)IBA 01/2021 - 05/2018
2	VaccinesIBA 01/2021 - 01/2021
2	Acid CeramidaseIBA 06/2020 - 01/2015
2	taxaneIBA 01/2020 - 05/2018
2	lipid transfer protein (glycolipid transfer protein)IBA 03/2019 - 11/2014
2	ErbB Receptors (EGF Receptor)IBA 08/2018 - 01/2007
2	Estrogens (Estrogen)FDA Link 04/2018 - 01/2013
2	Immunoglobulin E (IgE)IBA 06/2016 - 01/2016
2	BI 2536IBA 01/2015 - 05/2014
2	EnzymesIBA 01/2015 - 01/2014
2	AntibodiesIBA 01/2015 - 12/2013
2	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 02/2012
2	BI 6727IBA 01/2015 - 01/2015
2	AerosolsIBA 08/2014 - 01/2013
2	Tryptases (Tryptase)IBA 09/2013 - 01/2012
1	Cytostatic AgentsIBA 06/2022
1	PlacebosIBA 05/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	AlarminsIBA 01/2022
1	Death-Associated Protein KinasesIBA 01/2022
1	Thymic Stromal LymphopoietinIBA 01/2022
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2022
1	PAK inhibitor MRIA9IBA 07/2021
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 05/2021
1	onvansertibIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021

Therapy/Procedure

32	Therapeutics 06/2022 - 08/2002
10	Drug Therapy (Chemotherapy) 11/2021 - 10/2011
4	Immunotherapy 06/2021 - 01/2015
3	Uterine Myomectomy 02/2022 - 10/2017
3	Hysterectomy 10/2019 - 07/2011
2	Laparotomy 02/2022 - 10/2017
2	Length of Stay 02/2022 - 01/2019
2	Adjuvant Chemotherapy 01/2020 - 02/2015
2	Radiotherapy 01/2019 - 01/2017
2	Neoadjuvant Therapy 10/2013 - 01/2006
1	Operative Surgical Procedures 03/2022
1	Uterine Artery Embolization 02/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Adjuvant Radiotherapy 01/2022
1	Precision Medicine 11/2021
1	Chemoradiotherapy 09/2021
1	Emergency Treatment 01/2021